In vivo experiments demonstrate that ASH2L‐K312‐lac promotes HCC malignant progression and is positively correlated with tumor microvessel density, and vascular endothelial growth factor A (VEGFA) is identified as the key mediator in ASH2L‐K312‐lac‐induced angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.